![Favorite pages[Japanese page]](/files/000137013.png){kind=small}
](/files/000137010.png){kind=small}
- Home
- Regulatory Science/The Science Board/Standard Development
- Standard Development
- Japanese Pharmacopoeia
- Meetings & Events
- Report of the Japanese Pharmacopoeia 130th Anniversary Symposium - Challenges for the future -
Here begins the text.
Report of the Japanese Pharmacopoeia 130th Anniversary Symposium - Challenges for the future -
Outline of the Japanese Pharmacopoeia 130th Anniversary Symposium
Date: September 15, 2016
Venue: Nadao Hall (Tokyo, Kasumigaseki)
Organizer:
Ministry of Health, Labour and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA)
Co-Organizers:
Federation of Pharmaceutical Manufacturers' Association of Japan (FPMAJ) and Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ)
Presentation Slides
Part 1: Japanese Pharmacopoeia 130th Anniversary Ceremony
Moderator: Dr. Seiko Miyazaki (PMDA)
| Title | Speaker |
| Address | Director-General, Pharmaceutical and Environmental Health Bureau, MHLW Mr. Toshihiko Takeda |
| Salute from the Organizer | Chief Executive, PMDA Dr. Tatsuya Kondo |
| Congratulations | President, PAFSC & Chairman, JP Committee Dr. Mitsuru Hashida |
| Congratulations | President, FPMAJ Mr. Masayo Tada |
| Congratulations | President, PSJ Dr. Shigeru Ohta |
Part 2: Japanese Pharmacopoeia 130th Anniversary Symposium
Moderator for Session 1: Dr. Seiko Miyazaki (PMDA)
Moderator for Sessions 2 and after: Dr. Mayumi Shikano (PMDA)
| Title | Speaker |
| Keynote Address "Advances in Pharmaceutical Regulations in Japan and the Path of the Japanese Pharmacopoeia" |
Councilor for Pharmaceutical Affairs, MHLW Mr. Kazuhiko Mori |
| Session 1 Expectation for the future and the role of the JP |
Director-General, NIHS Dr. Toru Kawanishi Chairman, Pharmacopoeial Committee, FPMAJ Mr. Tomomi Kawamata President, Japan Self-Medication Industry Dr. Tatsuo Kurokawa Senior Managing Director, PMRJ Mr. Shigeki Tsuda |
| Session 2 Latest trends and future efforts of each world Pharmacopoeia in the progress of globalization |
Director, European Directorate for the Quality of Medicines & HealthCare, Council of Europe Dr. Susanne Keitel Chief Science Officer and Chair, Council of Experts, United States Pharmacopeia Dr. Jaap Venema Deputy Director of Comprehensive Division, Chinese Pharmacopoeia Commission Dr. Zonghua Song Secretary-cum-Scientific Director, Indian Pharmacopoeia Commission Dr. G.N. Singh Regulation and Health Surveillance Expert, Head of Brazilian Farmacopoeia Coordination Mr. Varley Dias Sousa Office Director, Office of Standards and Guidelines Development, PMDA Dr. Seiko Miyazaki |
| Session 3 Outcome of the 7th International Meeting of World Pharmacopoeias and its Future Prospects |
Group Lead, Medicines Quality Assurance, World Health Organization Dr. Sabine Kopp |
| Roundtable Discussion Vision for the future of the Pharmacopoeia and international harmonization of pharmacopoeia |
Facilitator: Dr. Toru Kawanishi Panelist: All the Speakers of Session2 and 3 Director, Division of Pharmacopoeia and Standards for Drugs, Office of Standards and Guidelines Development, PMDA, Dr. Naoyuki Yabana |
| Closing remarks | Director, Pharmaceutical Evaluation Division, Pharmaceutical and Environmental Health Bureau, MHLW Mr. Masanobu Yamada |